CompletedPhase 4

Levothyroxine for Children With Euthyroid Sick Syndrome

Mexico80 participantsStarted 2012-01

Plain-language summary

The purpose of this study is to determine whether levothyroxine is effective and safe in the treatment of children with euthyroid sick syndrome, hospitalized in a pediatric intensive care unit.

Who can participate

Age range1 Month – 17 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * All children aged 1 month to 17 years. * Admitted to pediatric intensive care unit. * TSH and thyroid hormones below age specific levels. Exclusion Criteria: * Known thyroid condition. * Brain death. * Gut conditions that contraindicate oral route. * Readmissions to intensive care unit.

What they're measuring

All cause mortality

Timeframe: participants will be followed for the duration of hospital stay, an expected average of 3 weeks

Trial details

NCT IDNCT01631305

SponsorSinaloa Pediatric Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2013-12

View on ClinicalTrials.gov More Euthyroid Sick Syndrome trials